Back to search

Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate Cancer

Data up to Jan 2025

Published2000
Citations185
References39

Total Citations Per Year

Abstract

References (39)

Unconventional Medicine in the United States -- Prevalence, Costs, and Patterns of Use

1993 • 4,259 citations

Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

1999 • 994 citations

Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer

1998 • 857 citations

Inhibitory Effect of Tumor Metastasis in Mice by Saponins, Ginsenoside-Rb2, 20(R)- and 20(S)-Ginsenoside-Rg3, of Red ginseng.

1995 • 376 citations

Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study.

1998 • 334 citations

Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer

1998 • 297 citations

Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm.

1997 • 215 citations

Inhibition of Tumor Angiogenesis and Metastasis by a Saponin of Panax ginseng, Ginsenoside-Rb2.

1994 • 211 citations

Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762

1986 • 190 citations

Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines

1994 • 181 citations

A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer

1998 • 181 citations

Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives

1992 • 174 citations

Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.

1996 • 126 citations

PREVALENCE AND PATTERNS OF THE USE OF COMPLEMENTARY THERAPIES AMONG PROSTATE CANCER PATIENTS: AN EPIDEMIOLOGICAL ANALYSIS

1999 • 126 citations

Cell Death Induced by Baicalein in Human Hepatocellular Carcinoma Cell Lines

1996 • 113 citations

Complete amino acid sequence of an immunomodulatory protein, ling zhi-8 (LZ-8)

1989 • 106 citations

PC‐SPES, a dietary supplement for the treatment of hormone‐refractory prostate cancer

2000 • 94 citations

Antitumor Active Polysaccharides from the Chinese MushroomSongshan Lingzhi, the Fruiting Body ofGanoderma tsugae

1993 • 94 citations

Identification of antimicrobial and antioxidant constituents from licorice of Russian and Xinjiang origin.

1989 • 89 citations

Anticarcinogenic effect of long-term oral administration of red ginseng on newborn mice exposed to various chemical carcinogens.

1983 • 87 citations

PC-SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo

2000 • 84 citations

A PHASE 1-2 TRIAL OF DIETHYLSTILBESTROL PLUS LOW DOSE WARFARIN IN ADVANCED PROSTATE CARCINOMA

1999 • 81 citations

Effects of a phytotherapeutic agent, PC‐SPES, on prostate cancer: a preliminary investigation on human cell lines and patients

1999 • 72 citations

Inhibition of Mutagenicity inSalmonella typhimuriumbyGlycyrrhiza glabraExtract, Glycyrrhizinic Acid and 18α- and 18β-Glycyrrhetinic Acids

1993 • 71 citations

Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen‐responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC‐SPES

1997 • 70 citations

In vitro induction of differentiation by ginsenosides in F9 teratocarcinoma cells

1996 • 66 citations

Steroid hormone-binding proteins in blood plasma

1972 • 65 citations

Reversal of Daunomycin and Vinblastine Resistance in Multidrug-Resistant P388 Leukemiain vitrothrough Enhanced Cytotoxicity by Triterpenoids

1995 • 60 citations

Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer.

1999 • 58 citations

Effects of baicalein and esculetin on transduction signals and growth factors expression in T-lymphoid leukemia cells

1994 • 58 citations

Antitumor activity of Sarcodon aspratus (BERK.) S. ITO and Ganoderma lucidum (FR.) KARST.

1989 • 55 citations

Antitumor Active Protein-containing Glycans from the Chinese Mushroom Songshan Lingzhi,Ganoderma tsugaeMycelium

1994 • 55 citations

Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease

1999 • 41 citations

A Modification of Simon's Optimal Design for Phase II Trials When the Criterion Is Median Sample Size

1999 • 29 citations

Effects of Ganoderma Lucidum and Krestin on Cellular Immunocompetence in γ-Ray-irradiated Mice

1995 • 28 citations

Idiopathic Thromboembolism as the Presenting Sign of Occult Prostate Cancer

1998 • 18 citations

Acid phosphatase: defining a role in androgen-independent prostate cancer

1996 • 15 citations

Survey of UsToo Members and Other Prostate Cancer Patients to Evaluate the Efficacy and Safety of PC-SPES.

1999 • 14 citations

Effect of glycyrrhetinic acid on DNA damage and unscheduled DNA synthesis induced by benzo(a)pyrene.

1995 • 8 citations

Cited By (0)

No citing papers found in database

Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate… (2000) – Journal of Clinical Oncology | Metascience Observatory Explorer